Tarsus Pharmaceuticals (TARS)

• Market cap: $3.46B
• 1 day: -0.55%
• 5 days: 0.58%
• 1 month: 1.94%
• 3 months: 37.17%
• 6 months: 101.23%
• Year to date: 47.82%
• 1 year: 49.03%
• 5 years: 94.47%
• 10 years: 296.11%
• Sector: Healthcare
• Industry: Biotechnology

About: Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Employees: 323